Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Likelihood of Down Syndrome with 3 Soft Markers and Outflow Tract Heart Defect

Understanding the Risk Factors

  • The presence of multiple soft markers substantially increases the risk of aneuploidy compared to isolated soft markers 1, 2
  • Cardiac defects, particularly outflow tract abnormalities, are strongly associated with Down syndrome 3
  • Approximately 25-30% of congenital heart defects are considered "syndromic," with Down syndrome being one of the most common genetic syndromes associated with CHDs 3

Risk Assessment Algorithm

  • A detailed obstetrical ultrasound examination is indicated when multiple soft markers are identified 1, 2
  • The approach to evaluation should be individualized for multiple soft markers or structural abnormalities 1
  • Multiple soft markers significantly increase likelihood ratios (LRs) for Down syndrome 1
  • Likelihood ratios >10 confer a substantial increase in the likelihood of Down syndrome 1
  • Cardiac defects, especially outflow tract abnormalities, are among the strongest indicators of Down syndrome 3

Management Recommendations

  • Diagnostic testing is recommended rather than just screening when multiple soft markers and a cardiac defect are present 1, 2, 3
  • Cell-free DNA (cfDNA) screening alone is insufficient in this scenario due to the high likelihood of aneuploidy 4, 6
  • Amniocentesis or chorionic villus sampling should be offered for definitive diagnosis 6, 7
  • A fetal echocardiogram is essential for detailed evaluation of the cardiac defect 8

Important Considerations

  • Even with negative screening tests (serum or cfDNA), the presence of multiple soft markers with a cardiac defect warrants diagnostic testing 1, 4
  • Only diagnostic testing (amniocentesis or CVS) completely removes residual risk for aneuploidy detection 4
  • Third-trimester ultrasound evaluation should be performed to reassess fetal growth and development 8
  • Genetic counseling should be provided to discuss implications and management options 3, 6

Common Pitfalls to Avoid

  • Relying solely on screening tests when multiple markers and structural anomalies are present 4, 6
  • Failing to perform a detailed cardiac evaluation when soft markers are identified 5, 8
  • Underestimating the significance of the combination of multiple soft markers with cardiac defects 1

REFERENCES